Efficacy and safety of EGFR inhibitor gefitinib in recurrent or metastatic cervical cancer: a preliminary report

There has been growing interest in the use of epidermal growth factor receptor inhibitors in various cancers. The study was conducted to evaluate the efficacy and safety of gefitinib as a monotherapy in patients with recurrent or metastatic cervical cancer. Patients with cervical carcinoma who exper...

Descripción completa

Detalles Bibliográficos
Autores principales: Krishna, Abhishek, Sathya, M., Mukesh, S., Athiyamaan, M. S., Banerjee, Sourjya, Sunny, Johan, Srinivas, Challapalli, Lobo, Dilson, Makkapatti, Bharat Sai, Jawahar, Vaishak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264517/
https://www.ncbi.nlm.nih.gov/pubmed/37310466
http://dx.doi.org/10.1007/s12032-023-02070-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264517/
https://www.ncbi.nlm.nih.gov/pubmed/37310466
http://dx.doi.org/10.1007/s12032-023-02070-1

Ejemplares similares